Cinchocaine
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | topical, intravenous (equine euthanasia) |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C20H29N3O2 |
Molar mass | 343.463 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Cinchocaine |
Articles |
---|
Most recent articles on Cinchocaine Most cited articles on Cinchocaine |
Media |
Powerpoint slides on Cinchocaine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cinchocaine at Clinical Trials.gov Clinical Trials on Cinchocaine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cinchocaine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cinchocaine Discussion groups on Cinchocaine Patient Handouts on Cinchocaine Directions to Hospitals Treating Cinchocaine Risk calculators and risk factors for Cinchocaine
|
Healthcare Provider Resources |
Causes & Risk Factors for Cinchocaine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cinchocaine (INN/BAN) or dibucaine (USAN) is an amide local anesthetic. Among the most potent and toxic of the long-acting local anesthetics, current use of cinchocaine is generally restricted to spinal and topical anesthesia.[1][2] It is sold under the brand names Cincain, Nupercainal, Nupercaine and Sovcaine.
Medical use
Cinchocaine is the active ingredient in some topical hemorrhoid creams such as Proctosedyl. It is also a component of the veterinary drug Somulose, used for euthanasia of horses and cattle.
Physical properties
Cinchocaine is relatively insoluble in alkaline aquatic solutions.
See also
References
Further reading
- Abdel-Ghani N, Youssef A, Awady M (2005). "Cinchocaine hydrochloride determination by atomic absorption spectrometry and spectrophotometry". Farmaco. 60 (5): 419–24. doi:10.1016/j.farmac.2005.03.001. PMID 15910814.
- Souto-Padron T, Lima AP, de Oliveira Ribeiro R. (2006). "Effects of dibucaine on the endocytic/exocytic pathways in Trypanosoma cruzi". Parasitol Res. 99 (4): 317–20. doi:10.1007/s00436-006-0192-1. PMID 16612626.
- Nounou M, El-Khordagui L, Khalafallah N (2005). "Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles". Acta Pol Pharm. 62 (5): 369–79. PMID 16459486.
- Aroti,A.;Leontidis, E. (2001). "Simultaneous Determination of the Ionization Constant and the Solubility of Sparingly Soluble Drug Substances. A Physical Chemistry Experiment". Journal of Chemical Education. 78 (6): 786–788. doi:10.1021/ed078p786.
Template:Vasoprotectives Template:Antipruritics
Template:Dermatologic-drug-stub Template:Nervous-system-drug-stub
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Drugboxes which contain changes to watched fields
- CS1 maint: Multiple names: authors list
- Drug
- Local anesthetics
- Quinolines
- Phenol ethers
- Amides